Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review

  • ID: 4284598
  • SWOT Analysis
  • 46 pages
  • GlobalData
  • Eagle Pharmaceuticals Inc
1 of 5
Eagle Pharmaceuticals Inc (EGRX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Eagle Pharmaceuticals Inc (Eagle Pharma) is a provider of pharmaceutical injectables. The company’s commercial product portfolio includes Ryanodex for exertional heatstroke; Argatroban for thrombosis; diclofenac sodium misoprostol forosteoarthritis for rheumatoid arthritis; and docetaxel injection for oncology. Eagle pharma’s product pipeline encompasses investigational candidates such as Bendamustine RTD for chronic lymphocytic leukemia and non-Hodgkin’s lymphoma; Bivalirudin for percutaneous transluminal angioplasty; and Pemetrexed for locally advanced or metastatic non-small cell lung cancer and mesothelioma. The company’s products cater to patients and healthcare professionals in the areas of critical care, orphan diseases, and oncology. Eagle Pharmaceuticals is headquartered in New Jersey, the US.

Eagle Pharmaceuticals Inc Key Recent Developments

May 15,2017: Eagle Pharmaceuticals Appoints Pete A. Meyers as Chief Financial Officer
May 08,2017: Eagle Pharmaceuticals Reports First Quarter 2017 Results
Mar 16,2017: Eagle Pharmaceuticals Appoints Richard A. Edlin to Board of Directors
Mar 01,2017: Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results
Dec 19,2016: Eagle Pharmaceuticals Announces David Pernock as President and Chief Commercial Officer

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5
Section 1 - About the Company
Eagle Pharmaceuticals Inc - Key Facts
Eagle Pharmaceuticals Inc - Key Employees
Eagle Pharmaceuticals Inc - Major Products and Services
Eagle Pharmaceuticals Inc - History
Eagle Pharmaceuticals Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

Section 2 - Company Analysis
Eagle Pharmaceuticals Inc - Business Description
Eagle Pharmaceuticals Inc - SWOT Analysis
SWOT Analysis - Overview
Eagle Pharmaceuticals Inc - Strengths
Eagle Pharmaceuticals Inc - Weaknesses
Eagle Pharmaceuticals Inc - Opportunities
Eagle Pharmaceuticals Inc - Threats
Eagle Pharmaceuticals Inc - Key Competitors

Section 3 - Company Financial Ratios
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

Section 4 - Company’s Lifesciences Financial Deals and Alliances
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Eagle Pharmaceuticals Inc, Recent Deals Summary

Section 5 - Company’s Recent Developments
May 15, 2017: Eagle Pharmaceuticals Appoints Pete A. Meyers as Chief Financial Officer
May 08, 2017: Eagle Pharmaceuticals Reports First Quarter 2017 Results
Mar 16, 2017: Eagle Pharmaceuticals Appoints Richard A. Edlin to Board of Directors
Mar 01, 2017: Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2016 Results
Dec 19, 2016: Eagle Pharmaceuticals Announces David Pernock as President and Chief Commercial Officer
Nov 09, 2016: Eagle Pharmaceuticals Reports Third Quarter 2016 Results
Aug 09, 2016: Eagle Pharmaceuticals Reports Second Quarter 2016 Results
Jul 05, 2016: Eagle Pharmaceuticals Announces Changes to Its Board of Directors; Director, Michael Graves Appointed Chairman
May 09, 2016: Eagle Pharmaceuticals Reports First Quarter 2016 Results; Bendeka Achieves 71% Total Market Share
Feb 25, 2016: Eagle Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Results

Section 6 - Appendix
Methodology
Ratio Definitions
About
Contact
Disclaimer

List of Tables
Eagle Pharmaceuticals Inc, Key Facts
Eagle Pharmaceuticals Inc, Key Employees
Eagle Pharmaceuticals Inc, Major Products and Services
Eagle Pharmaceuticals Inc, History
Eagle Pharmaceuticals Inc, Subsidiaries
Eagle Pharmaceuticals Inc, Key Competitors
Eagle Pharmaceuticals Inc, Ratios based on current share price
Eagle Pharmaceuticals Inc, Annual Ratios
Eagle Pharmaceuticals Inc, Annual Ratios (Cont...1)
Eagle Pharmaceuticals Inc, Annual Ratios (Cont...2)
Eagle Pharmaceuticals Inc, Interim Ratios
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Eagle Pharmaceuticals Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
Eagle Pharmaceuticals Inc, Performance Chart (2012 - 2016)
Eagle Pharmaceuticals Inc, Ratio Charts
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Eagle Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Threshold Pharmaceuticals Inc
  • OncoMed Pharmaceuticals Inc
  • Cipher Pharmaceuticals Inc
  • Agios Pharmaceuticals Inc
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll